Endocr Relat Cancer. 2006 Jun;13(2):273-8.

Insulin-like growth factor (IGF)-I, IGF binding protein-3, and breast cancer risk: eight years on.

Source

Department of Surgery, Christie Hospital NHS Trust, Wilmslow Road, Manchester M20 4BX, UK. arenehan@picr.man.ac.uk

Abstract

Insulin-like growth factor (IGF)-I, and its main binding protein, IGFBP-3, are multi-functional regulatory peptides of cell growth and survival, attributes important for tumourigenesis. Following seminal work published in 1998, it has been hypothesised that circulating concentrations of these growth factors may be associated with cancer risk. Systematic reviews have reported that high normal range circulating levels of total IGF-I predict for pre- but not post-menopausal breast cancer. By contrast, associations with circulating IGFBP-3 have been inconsistent. A cumulative meta-analysis demonstrates that earlier reported positive associations between IGFBP-3 and pre-menopausal breast cancer risk now seem less clear as large-size cohorts are published. The reasons are complex and include differences in study design, lack of standardisation between assays, and variations in IGFBP-3 proteolytic activity--these are discussed in this commentary.

PMID:: 16728563; [PubMed - indexed for MEDLINE]

Free full text

Publication Types, MeSH Terms, Substances

Publication Types

Review

MeSH Terms

Substances

LinkOut - more resources

Full Text Sources

Other Literature Sources

Medical

Breast Cancer - MedlinePlus Health Information

Libraries

LinkOut Holdings

Supplemental Content

Related citations

Insulin-like growth factor-I, its binding proteins (IGFBP-1 and IGFBP-3), and growth hormone and breast cancer risk in The Nurses Health Study II. [Endocr Relat Cancer. 2006]
Insulin-like growth factor-I, its binding proteins (IGFBP-1 and IGFBP-3), and growth hormone and breast cancer risk in The Nurses Health Study II.
Schernhammer ES, Holly JM, Hunter DJ, Pollak MN, Hankinson SE. Endocr Relat Cancer. 2006 Jun; 13(2):583-92.
Circulating levels of insulin-like growth factors, their binding proteins, and breast cancer risk. [Cancer Epidemiol Biomarkers Prev. 2005]
Circulating levels of insulin-like growth factors, their binding proteins, and breast cancer risk.
Schernhammer ES, Holly JM, Pollak MN, Hankinson SE. Cancer Epidemiol Biomarkers Prev. 2005 Mar; 14(3):699-704.
Review Insulin-like growth factor (IGF)-I, IGF binding protein-3, and cancer risk: systematic review and meta-regression analysis. [Lancet. 2004]
Review Insulin-like growth factor (IGF)-I, IGF binding protein-3, and cancer risk: systematic review and meta-regression analysis.
Renehan AG, Zwahlen M, Minder C, O'Dwyer ST, Shalet SM, Egger M. Lancet. 2004 Apr 24; 363(9418):1346-53.
Circulating insulin-like growth factor-I and binding protein-3 and the risk of breast cancer. [Cancer Epidemiol Biomarkers Prev. 2007]
Circulating insulin-like growth factor-I and binding protein-3 and the risk of breast cancer.
Baglietto L, English DR, Hopper JL, Morris HA, Tilley WD, Giles GG. Cancer Epidemiol Biomarkers Prev. 2007 Apr; 16(4):763-8.
Review Polymorphisms and circulating levels in the insulin-like growth factor system and risk of breast cancer: a systematic review. [Cancer Epidemiol Biomarkers Prev. 2005]
Review Polymorphisms and circulating levels in the insulin-like growth factor system and risk of breast cancer: a systematic review.
Fletcher O, Gibson L, Johnson N, Altmann DR, Holly JM, Ashworth A, Peto J, Silva Idos S. Cancer Epidemiol Biomarkers Prev. 2005 Jan; 14(1):2-19.

See reviews... See all...

Cited by 21 PubMed Central articles

A moderate elevation of circulating levels of IGF-I does not alter ErbB2 induced mammary tumorigenesis. [BMC Cancer. 2011]
A moderate elevation of circulating levels of IGF-I does not alter ErbB2 induced mammary tumorigenesis.
Dearth RK, Kuiatse I, Wang YF, Liao L, Hilsenbeck SG, Brown PH, Xu J, Lee AV. BMC Cancer. 2011 Aug 25; 11:377. Epub 2011 Aug 25.
Insulin-like growth factor-dependent proliferation and survival of triple-negative breast cancer cells: implications for therapy. [Neoplasia. 2011]
Insulin-like growth factor-dependent proliferation and survival of triple-negative breast cancer cells: implications for therapy.
Davison Z, de Blacquière GE, Westley BR, May FE. Neoplasia. 2011 Jun; 13(6):504-15.
A cross-sectional study of different patterns of oral contraceptive use among premenopausal women and circulating IGF-1: implications for disease risk. [BMC Womens Health. 2011]
A cross-sectional study of different patterns of oral contraceptive use among premenopausal women and circulating IGF-1: implications for disease risk.
Blackmore KM, Wong J, Knight JA. BMC Womens Health. 2011 May 20; 11:15. Epub 2011 May 20.

See all...

Related information

Related Citations
Calculated set of PubMed citations closely related to the selected article(s) retrieved using a word weight algorithm. Related articles are displayed in ranked order from most to least relevant, with the “linked from” citation displayed first.
Substance (MeSH Keyword)
PubChem chemical substance (submitted) records that are classified under the same Medical Subject Headings (MeSH) controlled vocabulary as the current articles.
Cited in PMC
Full-text articles in the PubMed Central Database that cite the current articles.

Recent activity

Clear Turn Off Turn On

Insulin-like growth factor (IGF)-I, IGF binding protein-3, and breast cancer ris...
Insulin-like growth factor (IGF)-I, IGF binding protein-3, and breast cancer risk: eight years on.
Endocr Relat Cancer. 2006 Jun ;13(2):273-8.

PubMed
Occult central nervous system involvement in patients with metastatic breast can...
Occult central nervous system involvement in patients with metastatic breast cancer: prevalence, predictive factors and impact on overall survival.
Ann Oncol. 2003 Jul ;14(7):1072-7.

PubMed
Metastatic breast cancer: clinical course, prognosis and therapy related to the ...
Metastatic breast cancer: clinical course, prognosis and therapy related to the first site of metastasis.
Breast Cancer Res Treat. 2000 Feb ;59(3):271-8.

PubMed
Is breast cancer prognosis inherited?
Is breast cancer prognosis inherited?
Breast Cancer Res. 2007 ;9(3):R39.

PubMed
Mechanisms of hormonal prevention of breast cancer.
Mechanisms of hormonal prevention of breast cancer.
Ann N Y Acad Sci. 2001 Dec ;952:23-35.

PubMed

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

PubMed

Display Settings:

Send to: